supp.fit

Inositol: study protocols

91 study groups say how much Inositol participants took a day. These are the doses the studies gave. They are not a recommendation.

Inositol: what the research found →

Dose per serving from products

6,110 products in our catalogue print how much Inositol a serving holds.

Most common: 25 mg to 50 mg, 17% of 6,110 products.

Dose per servingProducts
25 mcg or less
297
25 mcg to 50 mcg
412
50 mcg to 100 mcg
67
100 mcg to 250 mcg
16
250 mcg to 500 mcg
23
500 mcg to 1 mg
123
1 mg to 2.5 mg
228
2.5 mg to 5 mg
241
5 mg to 10 mg
496
10 mg to 25 mg
848
25 mg to 50 mg
1,052
50 mg to 100 mg
886
100 mg to 250 mg
501
250 mg to 500 mg
211
500 mg to 1 g
283
1 g to 2.5 g
372
over 2.5 g
54

Dose per serving from research

91 study groups in 78 studies say how much Inositol participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 2.5 g to 5 g, 46% of 91 study groups.

Daily doseStudy groups
250 mg or less
4
250 mg to 500 mg
3
500 mg to 1 g
7
1 g to 2.5 g
25
2.5 g to 5 g
42
5 g to 10 g
2
10 g to 25 g
8

Commonly used together

44 of 91 study groups took Inositol with something else. Shown: what 3 or more different studies gave. The 10 most common of 12.

What was given together, not what works together.

Taken withStudy groups
Folic Acid
37
Vitamin D
6
Zinc
6
Calcium
5
Iodine
5
Iron
5
Probiotics
5
Riboflavin
5
Vitamin B12
5
Vitamin B6
5

91 study groups

Study
Comparison of metformin plus myoinositol vs metformin alone in PCOS women undergoing ovulation induction cycles: randomized controlled trial
2019 · Group I · Infertile women with polycystic ovarian syndrome (PCOS)
1.8 g90 days60
Effects of Ziziphus jujuba, metformin, and myoinositol on pregnancy rates and metabolic parameters in infertile women with PCOS: a randomized controlled trial
2026 · Myoinositol + Placebo · Women aged 18–45 with PCOS and infertility
2 g12 weeks49
Impact of myoinositol with metformin and myoinositol alone in infertile PCOS women undergoing ovulation induction cycles - randomized controlled trial
2021 · Group II · Infertile women with polycystic ovarian syndrome undergoing ovulation induction cycles; age and sex details beyond women not reported
4 g26 weeks59
Impact of myoinositol with metformin and myoinositol alone in infertile PCOS women undergoing ovulation induction cycles - randomized controlled trial
2021 · Group I · Infertile women with polycystic ovarian syndrome undergoing ovulation induction cycles; age and sex details beyond women not reported
4 g26 weeks57
Myoinositol versus metformin pretreatment in GnRH-antagonist cycle for women with PCOS undergoing IVF: a double-blinded randomized controlled study
2022 · group 1 (Myo) · Infertile women with PCOS undergoing IVF; age and sex-specific details beyond women are not reported
4 g90 days50
A Randomized Phase IIb Trial of myo-Inositol in Smokers with Bronchial Dysplasia
2016 · myo-inositol group · Current and former smokers aged 45–79 years with at least a 30 pack-year smoking history and at least one histologically confirmed site of bronchial dysplasia
18 g26 weeks44
The 40:1 myo-inositol/D-chiro-inositol plasma ratio is able to restore ovulation in PCOS patients: comparison with other ratios
2019 · DCI alone · Women with polycystic ovary syndrome (PCOS); age not reported
4 g90 days8
Comparison of the effect of two combinations of myo-inositol and D-chiro-inositol in women with polycystic ovary syndrome undergoing ICSI: a randomized controlled trial
2019 · study group (SG) · Women with PCOS undergoing ICSI; age not reported
1.4 g12 weeks—
The effect of myo-inositol supplementation on the prevention of gestational diabetes in overweight pregnant women: a randomized, double-blind, controlled trial
2023 · myo-inositol group · Overweight pregnant women at 12–14 weeks of gestation
2 g10 weeks—
Myo-inositol rather than D-chiro-inositol is able to improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial
2011 · D-chiro-inositol group · Euglycemic patients with PCOS undergoing ovulation induction for ICSI; age and sex not otherwise specified
1.2 g—41
Myo-inositol Supplementation for Prevention of Gestational Diabetes in Obese Pregnant Women: A Randomized Controlled Trial
2015 · myo-inositol · Pregnant obese women (prepregnancy BMI 30 or greater)
4 g—110
Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial
2016 · myo-inositol group · Pregnant overweight, non-obese women with pre-pregnancy BMI ≥25 and <30 kg/m²
4 g—110
Effect of dietary myo-inositol supplementation on the insulin resistance and the prevention of gestational diabetes mellitus: an open-label, randomized controlled trial
2024 · MI group · Pregnant women at 11–13+6 weeks of gestation
4 g—100
Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women
2010 · MYO plus folic acid, with r-FSH added if no pregnancy occurred · Women with polycystic ovary syndrome, menstrual irregularities, chronic anovulation, and female infertility; ages not reported
4 g—60
myo-Inositol supplementation and onset of gestational diabetes mellitus in pregnant women with a family history of type 2 diabetes: a prospective, randomized, placebo-controlled study
2013 · myo-inositol group · Pregnant women recruited at 12–13 weeks’ gestation with a first-degree relative with type 2 diabetes, prepregnancy BMI <30 kg/m², and no pregestational diabetes or PCOS
4 g——
Comparison of the effect of two combinations of myo-inositol and D-chiro-inositol in women with polycystic ovary syndrome undergoing ICSI: a randomized controlled trial
2019 · control group (CG) · Women with PCOS undergoing ICSI; age not reported
1.13 g12 weeks—
Effects of inositol on ovarian function and metabolic factors in women with PCOS: a randomized double blind placebo-controlled trial
2003 · inositol · Women with oligomenorrhea and polycystic ovaries (PCOS)
200 mg14 weeks136
Myo-inositol rather than D-chiro-inositol is able to improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial
2011 · MyoInositol group · Euglycemic patients with PCOS undergoing ovulation induction for ICSI; age and sex not otherwise specified
4 g—43
Double-blind, placebo-controlled, crossover trial of inositol treatment for panic disorder
1995 · inositol · 21 patients with panic disorder, with or without agoraphobia
12 g4 weeks21
Double-blind, controlled, crossover trial of inositol versus fluvoxamine for the treatment of panic disorder
2001 · inositol · Adults with panic disorder
18 g30 days20
Double-blind, controlled trial of inositol treatment of depression
1995 · inositol · depressed patients; age and sex not reported
12 g4 weeks13
Inositol treatment of obsessive-compulsive disorder
1996 · inositol · patients with obsessive-compulsive disorder
18 g6 weeks13
Inositol as an add-on treatment for bipolar depression
2000 · inositol · Adult men and women with DSM-IV bipolar depression (21 with bipolar I and 3 with bipolar II)
12 g6 weeks12
Effect of inositol on bulimia nervosa and binge eating
2001 · inositol · 12 patients with bulimia nervosa and binge eating
18 g6 weeks12
Inositol treatment of Alzheimer's disease: a double blind, cross-over placebo controlled trial
1996 · inositol · 11 patients with Alzheimer's disease
6 g30 days11
The effect of a combination therapy with myo-inositol and a combined oral contraceptive pill versus a combined oral contraceptive pill alone on metabolic, endocrine, and clinical parameters in polycystic ovary syndrome
2011 · OCP plus myo-inositol · Patients with polycystic ovary syndrome; age and sex not specified
4 g1 year—
Efficacy of myo-inositol and d-chiro-inositol combination on menstrual cycle regulation and improving insulin resistance in young women with polycystic ovary syndrome: A randomized open-label study
2022 · MI + DCI · Young women aged 15–24 years with PCOS and delayed menstrual cycles
1.4 g26 weeks—
Follow-up and relapse analysis of an inositol study of depression
1995 · inositol · Patients with depression; age and sex not reported
12 g——
Effects of pinitol on glycemic control, insulin resistance and adipocytokine levels in patients with type 2 diabetes mellitus
2012 · pinitol · Adults with type 2 diabetes who had been taking oral hypoglycemic agents for at least 3 months
1.2 g—33
Higher Plasma Myo-Inositol in Pregnancy Associated with Reduced Postpartum Blood Loss: Secondary Analyses of the NiPPeR Trial
2024 · intervention supplement · Women aged 18–38 years planning conception; those included in this analysis conceived and had a singleton live birth
4 g—293
The effect of myo-inositol, vitamin D3 and melatonin on the oocyte quality and pregnancy in in vitro fertilization: a randomized prospective controlled trial
2020 · Study group · Women undergoing ICSI
3.2 g26 weeks50
Randomized, double blind placebo-controlled trial: effects of myo-inositol on ovarian function and metabolic factors in women with PCOS
2007 · myo-inositol plus folic acid · Women with oligomenorrhea and polycystic ovaries
4 g14 weeks45
A Prospective Study Evaluating the Effects of a Nutritional Supplement Intervention on Cognition, Mood States, and Mental Performance in Video Gamers
2019 · study supplement (nooLVL) · Healthy, non-smoking video gamers aged 18–40 years who played video games at least 5 hours per week
100 mg7 days30
[Diet, metformin and inositol in overweight and obese women with polycystic ovary syndrome: effects on body composition]
2012 · diet, metformin and MYO (D+M+I) · Overweight or obese women with polycystic ovary syndrome; age not reported
4 g90 days9
Myoinositol/folic acid combination for the treatment of erectile dysfunction in type 2 diabetes men: a double-blind, randomized, placebo-controlled study
2006 · myoinositol/folic acid combination · men with type 2 diabetes and erectile dysfunction
4 g——
Effects of myo-inositol supplementation on oocyte's quality in PCOS patients: a double blind trial
2011 · Group A · Women with polycystic ovary syndrome undergoing IVF
4 g90 days—
The myo-inositol effect on the oocyte quality and fertilization rate among women with polycystic ovary syndrome undergoing assisted reproductive technology cycles: a randomized clinical trial
2019 · study group · infertile women with PCOS undergoing assisted reproductive technology cycles; age not reported
4 g30 days—
The impact of myo-inositol supplementation on sleep quality in pregnant women: a randomized, double-blind, placebo-controlled study
2022 · myo-inositol supplementation · Pregnant women with low-risk singleton pregnancies, at least 14 weeks’ gestation
2 g10 weeks—
Improvement in biochemical manifestations of the serum and follicular fluid and ICSI outcomes in PCOS patients with myo-inositol administration: prospective randomized research
2025 · MI group · Infertile women with PCOS undergoing ovulation induction for ICSI; age not reported
4 g6 weeks—
Effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome: a perspective, randomized, placebo-controlled study
2011 · intervention group · Postmenopausal women with metabolic syndrome
4 g26 weeks—
A pilot study of D-chiro-inositol plus folic acid in overweight patients with type 1 diabetes
2017 · treated group · Overweight or obese patients with type 1 diabetes receiving intensive insulin therapy
1 g24 weeks—
Impact of preconception and antenatal supplementation with myo-inositol, probiotics, and micronutrients on offspring BMI and weight gain over the first 2 years
2024 · Intervention group · Offspring of women aged 18–38 years recruited while planning pregnancy; mothers received the supplement before conception and during pregnancy
4 g—287
Infant body composition in a randomised trial of a maternal nutritional supplement during preconception and pregnancy
2025 · Intervention · Women receiving the NiPPeR preconception and pregnancy intervention; offspring were followed during the first two years of life
4 g—268
Efficacy and Safety of "URSA Complex" in Subjects with Physical Fatigue: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial
2016 · URSA Complex · Adults older than 19 with persistent or chronic fatigue for at least 1 month and a baseline CIS score of at least 76; both sexes
20 mg4 weeks81
Effectiveness of a Food Supplement Based on Glucomannan, D-Chiro-Inositol, Cinnamomum zeylanicum Blume and Inulin in Patients with Metabolic Syndrome
2024 · oral supplement group · Adults over 18 with overweight and metabolic syndrome, including people with type 2 diabetes or impaired glucose tolerance; men and women
40 mg16 weeks29
A phytotherapic approach to reduce sperm DNA fragmentation in patients with male infertility
2017 · group A (Tradafertil) · men with previously diagnosed male infertility
1 g90 days—
Effects of d-chiro-inositol in lean women with the polycystic ovary syndrome
2002 · D-chiro-inositol group · Lean women with polycystic ovary syndrome, BMI 20.0–24.4 kg/m²
600 mg8 weeks10
Inositol for the prevention of neural tube defects: a pilot randomised controlled trial
2016 · young-adult research staff volunteers · Young-adult research staff volunteers, men and non-pregnant women
1.3 g7 days10
Effectiveness of dual combination therapy of acarbose plus metformin and acarbose plus myo-inositol in ameliorating the metabolic and endocrinologic complications of polycystic ovary syndrome - A randomized controlled trial
2024 · Group C · Women with polycystic ovary syndrome; age range not stated
2 g26 weeks54
Efficacy of myoinositol in treatment of gestational diabetes mellitus in Asian Indian women: A pilot randomized clinical trial
2021 · myoinositol group · Pregnant Asian Indian women with singleton pregnancies and gestational diabetes diagnosed between 14 and 28 weeks’ gestation
2 g123 days50
Daily phytate intake increases adiponectin levels among patients with diabetes type 2: a randomized crossover trial
2023 · InsP6-diet group · Adults aged 18 years or older with type 2 diabetes, stable glycemic control, and low dietary InsP6 intake; 23 women and 16 men completed the study
1.14 g12 weeks39
Metformin vs myoinositol: which is better in obese polycystic ovary syndrome patients? A randomized controlled crossover study
2017 · MYO (myoinositol) · Women aged 25–30 with obesity and polycystic ovary syndrome
2 g26 weeks34
Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome
1999 · D-chiro-inositol · Obese women with polycystic ovary syndrome
1.2 g7 weeks22
Inositol administration reduces oxidative stress in erythrocytes of patients with polycystic ovary syndrome
2012 · MYO · Normal-weight women with polycystic ovary syndrome
1.2 g12 weeks18
Effects of pinitol isolated from soybeans on glycaemic control and cardiovascular risk factors in Korean patients with type II diabetes mellitus: a randomized controlled study
2005 · pinitol · Korean patients with type II diabetes mellitus
1.2 g13 weeks—
Pinitol consumption improves liver health status by reducing oxidative stress and fatty acid accumulation in subjects with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial
2019 · low-dose group · Adults with ultrasonography-proven non-alcoholic fatty liver disease; age and sex not reported
300 mg12 weeks—
Pinitol consumption improves liver health status by reducing oxidative stress and fatty acid accumulation in subjects with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial
2019 · high-dose group · Adults with ultrasonography-proven non-alcoholic fatty liver disease; age and sex not reported
500 mg12 weeks—
One-year effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome
2012 · myo-inositol · postmenopausal women with metabolic syndrome
4 g1 year40
Effect of consumption of a carob pod inositol-enriched beverage on insulin sensitivity and inflammation in middle-aged prediabetic subjects
2016 · Inositol-enriched beverage (IEB) · Middle-aged adults with impaired fasting glucose (fasting glucose 100–125 mg/dL), grouped by BMI
4 g12 weeks24
Myo-inositol and melatonin in the menopausal transition
2017 · myo-inositol group · Women aged 45–55 years with at least 6 months of amenorrhea during the menopausal transition
4 g26 weeks20
Effect of inositol stereoisomers at different dosages in gestational diabetes: an open-label, parallel, randomized controlled trial
2018 · DCI treatment · Pregnant women with gestational diabetes mellitus
500 mg8 weeks20
Insulin-stimulated release of D-chiro-inositol-containing inositolphosphoglycan mediator correlates with insulin sensitivity in women with polycystic ovary syndrome
2008 · DCI group · Women aged 18–40 with polycystic ovary syndrome, chronic oligomenorrhea and hyperandrogenemia
2.4 g6 weeks6
High dose of d-chiro-inositol improves oocyte quality in women with polycystic ovary syndrome undergoing ICSI: a randomized controlled trial
2020 · high DCI content group · Women with PCOS undergoing ICSI
850 mg12 weeks5
A single acute dose of pinitol from a naturally-occurring food ingredient decreases hyperglycaemia and circulating insulin levels in healthy subjects
2013 · 2.5 g pinitol beverage · healthy subjects
2.5 g1 day—
A single acute dose of pinitol from a naturally-occurring food ingredient decreases hyperglycaemia and circulating insulin levels in healthy subjects
2013 · 4.0 g pinitol beverage · healthy subjects
4 g1 day—
A single acute dose of pinitol from a naturally-occurring food ingredient decreases hyperglycaemia and circulating insulin levels in healthy subjects
2013 · 6.0 g pinitol beverage · healthy subjects
6 g1 day—
Chronic consumption of an inositol-enriched carob extract improves postprandial glycaemia and insulin sensitivity in healthy subjects: A randomized controlled trial
2016 · inositol-enriched beverage (IEB) · healthy subjects; age and sex not specified
4.46 g12 weeks—
Comparison of two insulin sensitizers, metformin and myo-inositol, in women with polycystic ovary syndrome (PCOS)
2017 · myo-inositol · Women with PCOS and insulin resistance and/or hyperinsulinemia
4 g26 weeks—
The effect of metformin and myoinositol on metabolic outcomes in women with polycystic ovary syndrome: role of body mass and adiponectin in a randomized controlled trial
2022 · MI (myo-inositol) · Women with polycystic ovary syndrome (PCOS), including normal-weight and overweight/obese women; ages not reported
4 g26 weeks—
Myo-inositol nutritional supplement for prevention of gestational diabetes (EMmY): a randomised, placebo-controlled, double-blind pilot trial with nested qualitative study
2022 · intervention (myo-inositol) · Pregnant women aged at least 16 years with a singleton pregnancy at 12+0 to 15+6 weeks’ gestation and high risk of gestational diabetes
4 g—99
Comparison between effects of myo-inositol and D-chiro-inositol on ovarian function and metabolic factors in women with PCOS
2014 · D-chiro-inositol group · Women with PCOS and menstrual irregularities
1 g26 weeks25
Maternal B-vitamin and vitamin D status before, during, and after pregnancy and the influence of supplementation preconception and during pregnancy: Prespecified secondary analysis of the NiPPeR double-blind randomized controlled trial
2023 · intervention · Women planning pregnancy; generally healthy, recruited before conception
4 g—870
Myoinositol plus α-lactalbumin supplementation, insulin resistance and birth outcomes in women with gestational diabetes mellitus: a randomized, controlled study
2021 · Treated group · Women aged 18–44 with gestational diabetes mellitus and a singleton pregnancy
4 g60 days60
Effect of myo-inositol supplementation on ICSI outcomes among poor ovarian responder patients: A randomized controlled trial
2020 · Group A · Poor responder patients undergoing ICSI; age and sex details not reported
4 g—56
Treatment with combined resveratrol and myoinositol ameliorates endocrine, metabolic alterations and perceived stress response in women with PCOS: a double-blind randomized clinical trial
2023 · arm-2 · Women aged 20–35 years with obesity and oligo-anovulatory PCOS
2 g12 weeks55
Inositol for the prevention of neural tube defects: a pilot randomised controlled trial
2016 · inositol+FA group · Women aged 18–40 planning pregnancy, with a history of a previous neural tube defect-affected pregnancy
1 g—25
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes
2011 · study group · Women with gestational diabetes treated with diet
4 g8 weeks24
Myo-inositol and melatonin in the menopausal transition
2017 · myo-inositol plus melatonin group · Women aged 45–55 years with at least 6 months of amenorrhea during the menopausal transition
2 g26 weeks20
Effect of inositol stereoisomers at different dosages in gestational diabetes: an open-label, parallel, randomized controlled trial
2018 · MI treatment · Pregnant women with gestational diabetes mellitus
4 g8 weeks20
Effect of inositol stereoisomers at different dosages in gestational diabetes: an open-label, parallel, randomized controlled trial
2018 · MI plus DCI treatment · Pregnant women with gestational diabetes mellitus
1.13 g8 weeks20
Effect of Myo-Inositol Treatment on Serum Asprosin Levels of Pregnant Women: A Prospective Randomized Controlled Pilot Study
2025 · Group 1 · Pregnant women aged 18–40 without the stated exclusion conditions
4 g21 weeks20
Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome
2008 · Group A · Overweight patients with polycystic ovary syndrome; age and sex details not stated
2 g12 weeks10
Endocrine and clinical effects of myo-inositol administration in polycystic ovary syndrome. A randomized study
2013 · Group A · Overweight patients with polycystic ovary syndrome; age and sex not specified
2 g12 weeks10
High dose of d-chiro-inositol improves oocyte quality in women with polycystic ovary syndrome undergoing ICSI: a randomized controlled trial
2020 · low DCI content group · Women with PCOS undergoing ICSI
578 mg12 weeks6
Effect of myo-inositol and melatonin versus myo-inositol, in a randomized controlled trial, for improving in vitro fertilization of patients with polycystic ovarian syndrome
2016 · Group A · Women of reproductive age with polycystic ovarian syndrome undergoing IVF
4 g——
Effect of myo-inositol and melatonin versus myo-inositol, in a randomized controlled trial, for improving in vitro fertilization of patients with polycystic ovarian syndrome
2016 · Group B · Women of reproductive age with polycystic ovarian syndrome undergoing IVF
4 g——
Efficacy of myo-inositol and zinc on insulin resistance in a paediatric population with obesity
2025 · TRT · Patients aged 10–18 years with obesity and insulin resistance
2 g90 days—
The ameliorative effect of myo-inositol on apoptosis-related genes expression in cumulus cells of women with polycystic ovary syndrome undergoing ICSI and its relationship with the quality of oocyte and embryo
2025 · MYO group · Infertile women with PCOS undergoing ICSI; age range and sex beyond women not reported
4 g6 weeks—
Myo-Inositol, Probiotics, and Micronutrient Supplementation From Preconception for Glycemia in Pregnancy: NiPPeR International Multicenter Double-Blind Randomized Controlled Trial
2021 · Intervention · Women aged 18–38 planning to conceive within 6 months; recruited primarily from the community and followed through pregnancy.
4 g—870
Comparison between effects of myo-inositol and D-chiro-inositol on ovarian function and metabolic factors in women with PCOS
2014 · Myo-inositol group · Women with PCOS and menstrual irregularities
4 g26 weeks25
The effectiveness of inositol and metformin on infertile polycystic ovary syndrome women with resistant to letrozole
2019 · Group III · Infertile women with polycystic ovary syndrome who did not ovulate after letrozole treatment
4 g90 days—